CCL5 and neoplasm: Furthermore, ginseng-derived nanoparticles have been found to reprogram TAM, leading to increased release of CCL5 and CXCL9. This reprogramming synergizes with PD-1 treatment by recruiting CD8+ T cell into the tumor (54).